Abstract
Tido von Schoen-Angerer and colleagues discuss the new Affordable Medicines Facility for malaria (AMFm), which subsidizes and facilitates access to artemisinin-based combination therapy, and what mechanisms are needed to ensure it stays focused on quality patient care.
MeSH terms
-
Antimalarials / economics*
-
Antimalarials / supply & distribution
-
Antimalarials / therapeutic use
-
Artemisinins / economics*
-
Artemisinins / supply & distribution
-
Artemisinins / therapeutic use
-
Delivery of Health Care / economics
-
Delivery of Health Care / standards*
-
Drug Therapy, Combination
-
Financing, Organized*
-
Global Health
-
Health Services Accessibility* / economics
-
Humans
-
International Cooperation*
-
Malaria, Falciparum / drug therapy*
-
Malaria, Falciparum / economics
-
Quality of Health Care*
Substances
-
Antimalarials
-
Artemisinins
-
artemisinin